PMID- 38507910 OWN - NLM STAT- MEDLINE DCOM- 20240322 LR - 20240322 IS - 1833-3516 (Print) IS - 1833-3516 (Linking) VI - 54 IP - 1 DP - 2024 Mar 31 TI - Equipoise: an important ethical consideration when contemplating participation in a randomised controlled trial of hyperbaric oxygen treatment in necrotising soft tissue infections. PG - 57-60 LID - 10.28920/dhm54.1.57-60 [doi] AB - A proposal for a large, multi-centre, randomised controlled trial investigating the role of hyperbaric oxygen treatment (HBOT) in necrotising soft tissue infections (NSTI) has led to much discussion locally and internationally about whether participation is ethical for a centre where stakeholders already consider HBOT standard practice. This article systematically addresses the concept of clinical equipoise specific to the role of HBOT in NSTI, and presents a series of considerations to be taken into account by key stakeholders at potential participating sites. CI - Copyright: This article is the copyright of the authors who grant Diving and Hyperbaric Medicine a non-exclusive licence to publish the article in electronic and other forms. FAU - Devaney, Bridget AU - Devaney B AUID- ORCID: 0000-0001-6521-418X AD - Emergency and Trauma Centre, Alfred Health, Melbourne, Australia. AD - Department of Intensive Care and Hyperbaric Medicine, Alfred Health, Melbourne, Australia. AD - Department of Epidemiology and Preventative Medicine, Monash University, Melbourne, Australia. AD - Corresponding author: Dr Bridget Devaney, Head of Hyperbaric Medicine, Alfred Health, 55 Commercial Road, Melbourne, VIC 3004, Australia, b.devaney@alfred.org.au. LA - eng PT - Journal Article PT - Multicenter Study PT - Randomized Controlled Trial PL - Australia TA - Diving Hyperb Med JT - Diving and hyperbaric medicine JID - 101282742 RN - S88TT14065 (Oxygen) SB - IM MH - Humans MH - *Soft Tissue Infections/therapy MH - *Hyperbaric Oxygenation MH - Oxygen OTO - NOTNLM OT - Clinical trials OT - Ethics OT - Hyperbaric research EDAT- 2024/03/21 00:44 MHDA- 2024/03/22 06:44 CRDT- 2024/03/20 19:06 PHST- 2023/11/17 00:00 [received] PHST- 2024/01/19 00:00 [accepted] PHST- 2024/03/22 06:44 [medline] PHST- 2024/03/21 00:44 [pubmed] PHST- 2024/03/20 19:06 [entrez] AID - 10.28920/dhm54.1.57-60 [doi] PST - ppublish SO - Diving Hyperb Med. 2024 Mar 31;54(1):57-60. doi: 10.28920/dhm54.1.57-60.